Molecules 2012, 17(11), 12868-12881; doi:10.3390/molecules171112868
Article

Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats

Xiupu Shi 1 email, Sha Liao 2 email, Huijuan Mi 1 email, Changrun Guo 1 email, Dongli Qi 1 email, Fei Li 1 email, Chunfeng Zhang 1,* email and Zhonglin Yang 1,* email
1 State Key Laboratory of Natural Products and Functions, China Pharmaceutical University, No. 24 Tongjiaxiang, Nanjing 210009, China 2 College of Life Sciences, Northwest University, Taibai Road 229, Xi'an 710069, China
* Authors to whom correspondence should be addressed.
Received: 13 September 2012; in revised form: 26 October 2012 / Accepted: 29 October 2012 / Published: 1 November 2012
(This article belongs to the Section Natural Products)
PDF Full-text Download PDF Full-Text [786 KB, uploaded 1 November 2012 11:20 CET]
Abstract: Diabetic retinopathy is a complex disease that potentially involves increased production of advanced glycosylation end products (AGEs) and elevated aldose reductase (AR) activity, which are related with oxidative stress and inflammation. The aim of this study was to investigate the effects of hesperidin on retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Hesperidin (100, 200 mg/kg daily) was given to diabetic rats for 12 weeks. The blood-retina breakdown (BRB) was determined after 2 weeks of treatment followed by the measurement of related physiological parameters with ELISA kits and immunohistochemistry staining at the end of the study. Elevated AR activity and blood glucose, increased retinal levels of vascular endothelial growth factor (VEGF), ICAM-1, TNF-α, IL-1β and AGEs as well as reduced retina thickness were observed in diabetic rats. Hesperidin treatment significantly suppressed BRB breakdown and increased retina thickness, reduced blood glucose, AR activity and retinal TNF-α, ICAM-1, VEGF, IL-1β and AGEs levels. Furthermore, treatment with hesperidin significantly reduced plasma malondialdehyde (MDA) levels and increased SOD activity in diabetic rats. These data demonstrated that hesperidin attenuates retina and plasma abnormalities via anti-angiogenic, anti-inflammatory and antioxidative effects, as well as the inhibitory effect on polyol pathway and AGEs accumulation.
Keywords: hesperidin; diabetic retinopathy; anti-angiogenic effect; aldose reductase activity; AGEs accumulation

Supplementary Files

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Shi, X.; Liao, S.; Mi, H.; Guo, C.; Qi, D.; Li, F.; Zhang, C.; Yang, Z. Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats. Molecules 2012, 17, 12868-12881.

AMA Style

Shi X, Liao S, Mi H, Guo C, Qi D, Li F, Zhang C, Yang Z. Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats. Molecules. 2012; 17(11):12868-12881.

Chicago/Turabian Style

Shi, Xiupu; Liao, Sha; Mi, Huijuan; Guo, Changrun; Qi, Dongli; Li, Fei; Zhang, Chunfeng; Yang, Zhonglin. 2012. "Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats." Molecules 17, no. 11: 12868-12881.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert